Nom du produit:5-methyl-1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1H-1,2,3-triazole-4-carboxylic acid

IUPAC Name:5-methyl-1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1H-1,2,3-triazole-4-carboxylic acid

CAS:1251228-33-7
Formule moléculaire:C8H9N5O3
Pureté:95%+
Numéro de catalogue:CM470229
Poids moléculaire:223.19

Unité d'emballage Stock disponible Prix($) Quantité
CM470229-250mg 4-5 Weeks ʼnŹǵ
CM470229-500mg 4-5 Weeks ĽĽȎ
CM470229-1g 4-5 Weeks ưȎư

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1251228-33-7
Formule moléculaire:C8H9N5O3
Point de fusion:-
Code SMILES:CC1=NN=C(CN2N=NC(C(O)=O)=C2C)O1
Densité:
Numéro de catalogue:CM470229
Poids moléculaire:223.19
Point d'ébullition:
N° Mdl:MFCD16674351
Stockage:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.
Oxadiazoles
Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.

Related Products